MDB Capital Holdings, LLC (MDBH)
| Market Cap | 63.07M |
| Revenue (ttm) | 1.94M |
| Net Income (ttm) | -24.77M |
| Shares Out | 9.95M |
| EPS (ttm) | -2.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,313 |
| Open | 6.15 |
| Previous Close | 6.21 |
| Day's Range | 6.15 - 6.35 |
| 52-Week Range | 5.78 - 13.25 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2024 |
About MDBH
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer firm that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology research and developmen... [Read more]
Financial Performance
In 2023, MDB Capital Holdings, LLC's revenue was $6.00 million, an increase of 391.81% compared to the previous year's $1.22 million. Losses were -$6.97 million, 31.1% more than in 2022.
Financial StatementsNews
MDB Capital Holdings Provides Third Quarter 2024 Update
Addison, TX, Nov. 21, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today provi...
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
Project is part of the U.S. Department of Defense's BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development Project is part of the U.S. Department of Defen...
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to...
Invizyne Technologies Announces Closing of Initial Public Offering
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and che...
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology Underlying technology...
Invizyne Technologies Begins Trading on NASDAQ
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC” Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”
MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
Record date of July 22, 2024 set for allocation preferences Closing and trading expected on NASDAQ on or before August 15 Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (...
Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics
Transformative Innovations in MASH Diagnostics Dallas, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- PatentVest, the first integrated IP intelligence strategy and law firm, recently published a whitepaper ...
MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform
ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today an...
MDB Capital Expands Board, Appoints Daniel Torpey as New Director
Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB Capital”), a public venture platform focused on launching category-leading deep technology companies, ...
New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring
56% increase in global patent publications over the last five years signals growing interest in the cardiac monitoring market which is expected to grow to $3 billion per year by 2029 according to Stat...
MDB Capital Holdings Unveils Unified Corporate Branding
Addison, TX, May 22, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announ...
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in key roles includi...
MDB Capital Holdings Year-End Update
Addison, Texas, April 17, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, reporte...
MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time
Addison, Texas, April 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimiz...
MDB Capital Holdings Issues Annual Letter to Shareholders
Addison, TX, Jan. 31, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing ...
MDB Capital Holdings Reports Third Quarter 2023 Results
Addison, TX, Nov. 15, 2023 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing ...
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC , (NASDAQ:MDB...
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
Non-Dilutive Funding and Resources Provided to De-Risk Investment and Accelerate Commercialization Non-Dilutive Funding and Resources Provided to De-Risk Investment and Accelerate Commercialization
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy
Funding Supports Project to Optimize and Scale Up Isobutanol Production to Address Potential $27.4 Billion Sustainable Aviation Fuel Market Funding Supports Project to Optimize and Scale Up Isobutanol...
MDB Capital Holdings Begins Trading on NASDAQ
Public Venture Platform Company Will Trade Under Ticker Symbol "MDBH" ADDISON, TX / ACCESSWIRE / September 21, 2023 / MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB") a public venture platform with th...
MDB Capital Holdings Announces Closing of Public Offering of $20 Million
Shares to Begin Trading on NASDAQ on September 21, 2023 Under the Ticker Symbol "MDBH" ADDISON, TX / ACCESSWIRE / September 20, 2023 / MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public ventur...